Ironwood Pharma (IRWD) Posts Q1 Loss of 38c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LVS
9. LRCX
10. MRK

Go back to Ironwood Pharma (IRWD) Posts Q1 Loss of 38c/Share

Aegis Maintains Ironwood Pharma (IRWD) at Buy; Still Positive on LINZESS Amid Slower Start

April 29, 2014 12:02 PM EDT

Aegis Capital reaffirms its Buy rating and $16 target price on Ironwood Pharmaceuticals (Nasdaq: IRWD) following the company's Q1 report. Ahead of the bell, Ironwood posted Q1 loss of $.38 per share with revenue of $14.6 million, versus consensus estimates looking for a loss of $.44 per share with revenue of $8.52 million.

Analyst Ram Selvaraju commented, On its earnings conference call,... More